John Graham

JOHN GRAHAM is vice president and head of value, evidence and outcomes with GlaxoSmithKline research and development. He is also a member of the GSK Inclusion and Diversity Council and is active within GSK’s Women in Leadership program. His teams are recognized for their impact and leadership as well as the strength of diversity throughout leadership of the team. Graham is an industry leader and advocate for the integration of Real World Evidence with traditional clinical evidence to establish the true value of medicines and treatments for patients, providers and payers. He sits on multiple advisory boards and is active across advocacy organizations. Graham has published and presented on topics related to outcomes research, Real World Evidence as well as both metabolic and cardiovascular diseases. He holds a PharmD from Idaho State University and completed a primary care residency at the University of Nebraska Medical Center. @gsk